Gene fusion in prostate cancer - clinical applications in diagnosis, prognosis and therapy

被引：1
作者：
Schmidt, F. [2 ]
Scheble, V. [1 ]
Mertz, K. [3 ]
Perner, S. [1 ]
Rubin, M. A. [4 ]
机构：
[1] Univ Klinikum Tubingen, Ctr Comprehens Canc, Inst Pathol, Tubingen, Germany
[2] Johannes Gutenberg Univ Mainz, Urol Klin & Poliklin, Mainz, Germany
[3] Univ Klin Dermatol, Abt Immundermatol & Infektiose Hautkrankheiten, Vienna, Osterreich, Austria
[4] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2009年 / 134卷 / 28-29期
关键词：
prostate cancer; gene fusion; TMPRSS2; ERG; prognosis; biomarker; TMPRSS2; TRANSCRIPTS;
D O I：
10.1055/s-0029-1225305
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1483 / 1486
页数：4
相关论文
共 50 条
  • [21] Epidemiology, diagnosis and prognosis of prostate cancer
    Terrier, M.
    Terrier, J. E.
    Paparel, P.
    Morel-Journel, N.
    Baldini, A.
    Ruffion, A.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2017, 41 (05): : 329 - 334
  • [22] New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer
    Shariat, Shahrokh F.
    Karam, Jose A.
    Margulis, Vitaly
    Karakiewicz, Pierre I.
    BJU INTERNATIONAL, 2008, 101 (06) : 675 - 683
  • [23] miR-27b expression in diagnosis and evaluation prognosis of prostate cancer
    Li, Tian
    Sun, Xiangzhou
    Liu, Yifan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (12): : 11415 - 11424
  • [24] The role of miRNA in prostate cancer diagnosis, prognosis and treatment response: a narrative review
    Vazquez-Urrutia, Jorge Raul
    Torres-Bustamante, Maria Iyali
    Cerda-Cruz, Cesar Rodrigo
    Bravo-Cuellar, Alejandro
    Ortiz-Lazareno, Pablo Cesar
    FUTURE ONCOLOGY, 2023, 19 (01) : 77 - 93
  • [25] Significance of the TMPRSS2:ERG gene fusion in prostate cancer
    Hossain, Deloar
    Bostwick, David G.
    BJU INTERNATIONAL, 2013, 111 (05) : 834 - 835
  • [26] Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
    Norgaard, Maibritt
    Haldrup, Christa
    Storebjerg, Tine Maj
    Vestergaard, Else Marie
    Wild, Peter J.
    Hoyer, Soren
    Borre, Michael
    Orntoft, Torben Falck
    Sorensen, Karina Dalsgaard
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (09):
  • [27] Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy
    Rasteiro, Ana Mafalda
    e Lemos, Eva Sa
    Oliveira, Paula A.
    Gil da Costa, Rui M.
    VETERINARY SCIENCES, 2022, 9 (03)
  • [28] Clinical Implications of TMPRSS2-ERG Gene Fusion Expression in Patients With Prostate Cancer Treated With Radical Prostatectomy
    Rubio-Briones, Jose
    Fernandez-Serra, Antonio
    Calatrava, Ana
    Garcia-Casado, Zaida
    Rubio, Luis
    Bonillo, Miguel A.
    Iborra, Inmaculada
    Solsona, Eduardo
    Lopez-Guerrero, Jose A.
    JOURNAL OF UROLOGY, 2010, 183 (05) : 2054 - 2061
  • [29] Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development
    Bahmad, Hisham F.
    Jalloul, Mohammad
    Azar, Joseph
    Moubarak, Maya M.
    Samad, Tamara Abdul
    Mukherji, Deborah
    Al-Sayegh, Mohamed
    Abou-Kheir, Wassim
    FRONTIERS IN GENETICS, 2021, 12
  • [30] Artificial intelligence in clinical applications for lung cancer: diagnosis, treatment and prognosis
    Pei, Qin
    Luo, Yanan
    Chen, Yiyu
    Li, Jingyuan
    Xie, Dan
    Ye, Ting
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (12) : 1974 - 1983
12345